Search
Displaying 391–400 of 578 for “Retinitis pigmentosa”
-
AGTC Leverages Funding from the Foundation to Move Promising Treatments into Clinical Trials
Research NewsCompany Builds on FFB’s Initial Investment to Garner $265 Million in Therapy Development Funding
-
Foundation Investing in Drug to Slow Many Forms of RP
Research NewsThe Foundation Fighting Blindness Clinical Research Institute (FFB-CRI) has announced an investment of up to $7.5 million to advance the potential therapy into and through a Phase II clinical trial.
-
FFB-CRI Leads Effort to Identify Outcome Measures for Therapies in Clinical Trials
Research NewsImproved outcome measures will make clinical trials for degenerative retinal diseases — including age-related macular degeneration (AMD), the world’s leading cause of blindness in seniors, and inherited retinal conditions such as RP and Stargardt disease — less expensive to conduct and able to deliver more precise results.
-
To Treat an Inherited Retinal Disease, It's Good to Know Exactly What's Wrong with the Gene
Research NewsIdentifying mutations cannot only help deliver a prognosis for a patient, it can direct them to clinical trials for therapies to save their vision.
-
Building a Wiring Diagram for the Retina to Help Researchers Save and Restore Vision
Research NewsUnderstanding the pathways of the retinal neural network — and how they are rewired with aging and disease — is helpful in trying to save and restore vision.
-
Embrace Your Exceptions: A Mantra for Understanding Retinal-Disease Inheritance
Research NewsThe complex and elusive nature of these conditions can also extend to the way they are passed down in families, making diagnosis and prognosis quite challenging.
-
Researchers Identify Canine Model of LCA (NPHP5) — Pursue Gene Therapy
Research NewsThe investigators found that in canines, the retinal degeneration is remarkably similar to that in humans with NPHP5 mutations.
-
Research News
Dr. Weleber became the 10th recipient of the Foundation’s highest honor, named after FFB co-founder Lulie Gund, during the opening lunch of the VISIONS 2016 conference.
-
A Steady Hand in Saving Vision
Research NewsSubretinal injection is the most common form of delivery for gene therapies currently in clinical trials.
-
ARVO 2016: What Does It Take to Develop a Stem-Cell Therapy for the Retina?
Research NewsThere are innumerable considerations for researchers developing therapies.
.png)
